Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Biostar to Build Own Raw Material Processing Facility

publication date: Mar 10, 2009

Biostar Pharmaceuticals paid almost $3 million (20 million RMB) to purchase 8.6 acres of land on which it will build a raw material processing facility. Biostar plans to spend another $2.3 million (16 million RMB) to construct the plant, which will comprise about 6,000 square meters. The land is located in Xi'an, thirty-five kilometers from Biostar’s operating facility in Xian Yang, China, and only 5 kilometers from 80 acres of farmland that Biostar leased last fall. The company said the farmland will be used to grow herbs and plants that Biostar uses in its pharmaceutical products. More details...

Stock Symbol: (OTCBB: BSPM)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital